Marshall Hargrave is a stock analyst and writer with 10+ years of experience covering stocks and markets, as well as analyzing and valuing companies. Yarilet Perez is an experienced multimedia ...

Profit Formula: Doing business is no easy task. From negotiating the right price to selling a product at the best possible value, every step is aimed at maximizing profit. Whether you are a seller or ...

LAS VEGAS — Max Verstappen won the Las Vegas Grand Prix on Saturday night after capturing the lead from championship leader Lando Norris at the start and never looking back. The Formula 1 cars blasted ...

The grocery store formerly known as Steve’s 9th Street Supermarket in Park Slope has a new occupant. K Slope Market, a full-service supermarket and member of the Key Food Cooperative, opened its doors ...

U.S. fighter jets were scrambled Wednesday to identify and intercept four Russian warplanes flying near Alaska, the North American Aerospace Defense Command said in a statement. NORAD said two Russian ...

NATO jets intercepted two Russian SU-30 warplanes carrying supersonic missiles over the Baltic Sea as Vladimir Putin continues to taunt the West with aggressive shows of Moscow's military strength.

There were six violations of a restricted airspace over Bedminster, New Jersey, while President Donald Trump was staying at his residence there over the weekend, the U.S. Air Force said. One of those ...

While the path for any drug to go from lab research to commercialization takes years, Intercept Pharmaceuticals now stands as another example that a product’s market exit can also be long and winding.

Please provide your email address to receive an email when new articles are posted on . Intercept has voluntarily withdrawn its lone product, Ocaliva, from U.S. market for primary biliary cholangitis.

Sept 11 (Reuters) - Intercept Pharmaceuticals said on Thursday it is withdrawing its liver disease drug from the U.S. market following a request from the Food and Drug Administration. This comes as ...

After years of regulatory struggles for Intercept Pharmaceuticals and its liver disease drug Ocaliva (obeticholic acid), the FDA has called time on the drug's run in the U.S. market. The agency placed ...

People on board the boat off the coast of Venezuela that the U.S. military destroyed last Tuesday were said to have survived an initial strike, according to two American officials familiar with the ...